Abstract

The use of GnRH agonist trigger has been shown to reduce OHSS. However in autologous ART, previous meta-analysis suggested GnRH agonist trigger might lower clinical outcomes when compared to hCG trigger. Reducing the risk of OHSS without compromising pregnancy outcomes is of paramount importance in donor oocyte ART. Thus we compared clinical outcomes between donors receiving hCG or GnRH agonist triggers.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.